e-Therapeutics (LSE:ETX) Cyclically Adjusted PS Ratio : (As of Jun. 20, 2024)

e-Therapeutics Cyclically Adjusted PS Ratio Chart

e-Therapeutics Annual Data
	Trend	Jan14	Jan15	Jan16	Jan17	Jan18	Jan19	Jan20	Jan21	Jan22	Jan23
Cyclically Adjusted PS Ratio		Get a 7-Day Free Trial					-	18.75	123.41	241.31	117.06

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															-	241.31	-	117.06	-

Competitive Comparison of e-Therapeutics's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, e-Therapeutics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

e-Therapeutics's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, e-Therapeutics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where e-Therapeutics's Cyclically Adjusted PS Ratio falls into.

e-Therapeutics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

e-Therapeutics's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jan23 is calculated as:

For example, e-Therapeutics's adjusted Revenue per Share data for the fiscal year that ended in Jan23 was:

Current CPI (Jan23) = 124.8000.

e-Therapeutics Annual Data

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

e-Therapeutics  (LSE:ETX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

e-Therapeutics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description